EA
Roles
Therapeutic Areas
MIRA Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ketamir-2 (Ketamir) | Neuropathic Pain (NP) | Phase 1 |
| MIRA-55 | Anxiety & Cognitive Decline (e.g., early-stage dementia) | Preclinical |
Leadership Team at MIRA Pharmaceuticals
MD
Matthew Del Giudice
Director
NM
Ned Macpherson
Director
DN
Denil N. Shekhat
Director
IA
Itzchak Angel
Chief Scientific Advisor